Recombinant Human Interleukin-11 Combination Low-dose Rituximab in Immune Thrombocytopenia

Clinical trial NCT01317966 · WITHDRAWN

Trial details

NCT number: NCT01317966
Sponsor: Ming Hou
Status: WITHDRAWN
Study type: OBSERVATIONAL

Purpura, Thrombocytopenic, Idiopathic

Start date: 2011-03-01
Primary completion: 2011-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.